129 related articles for article (PubMed ID: 3119370)
21. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
[TBL] [Abstract][Full Text] [Related]
22. [Endocrine effects of laser vaporization of the ovaries in women with polycystic ovary syndrome].
Rossmanith WG; Keckstein J; Spatzier K; Lauritzen C
Gynakol Rundsch; 1991; 31 Suppl 2():333-5. PubMed ID: 1790971
[No Abstract] [Full Text] [Related]
23. Pituitary response during pulsatile luteinizing hormone-releasing hormone ovulation--induction in patients with clomiphene citrate-resistant polycystic ovary-like disease.
Burger CW; Korsen TJ; Schoemaker J
Gynecol Endocrinol; 1988 Mar; 2(1):19-33. PubMed ID: 3140589
[TBL] [Abstract][Full Text] [Related]
24. A combination of gonadotropin-releasing hormone analog and human menopausal gonadotropins for ovulation induction in premature ovarian failure.
Letterie G; Miyazawa K
Acta Obstet Gynecol Scand; 1989; 68(6):571-3. PubMed ID: 2520819
[TBL] [Abstract][Full Text] [Related]
25. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
Gonzalez F; Hatala DA; Speroff L
Am J Obstet Gynecol; 1991 Sep; 165(3):535-45. PubMed ID: 1832519
[TBL] [Abstract][Full Text] [Related]
26. Ovulation induction with pulsatile luteinizing releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: clinical results.
Burger CW; Korsen TJ; Hompes PG; van Kessel H; Schoemaker J
Fertil Steril; 1986 Dec; 46(6):1045-54. PubMed ID: 3096792
[TBL] [Abstract][Full Text] [Related]
27. Value of subcutaneous and intravenous pulsatile gonadotropin releasing hormone in polycystic ovary disease.
Saffan DS; Seibel MM
J Reprod Med; 1992 Jun; 37(6):545-51. PubMed ID: 1619610
[TBL] [Abstract][Full Text] [Related]
28. [Ovulation induction with pulsatile gonadotropin-releasing hormone and continuous human menopausal gonadotropin in polycystic ovarian disease].
Kuroda G
Nihon Naibunpi Gakkai Zasshi; 1987 Mar; 63(3):247-59. PubMed ID: 3111899
[TBL] [Abstract][Full Text] [Related]
29. Induction of ovulation with D-Trp6-LHRH combined with purified FSH in patients with polycystic ovarian disease.
Ayalon D; Ben-David M; Wohl R; Jaffe R; Vagman I; Eckstein N; Limor R; Comaru-Schally AM; Schally AV
Gynecol Endocrinol; 1988 Dec; 2(4):319-30. PubMed ID: 2976573
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of infertility due to polycystic ovary disease using a combination of luteinising hormone releasing hormone agonist and low dosage menotrophin.
Armitage M; Wilkin T; Dewbury K
Br Med J (Clin Res Ed); 1987 Jul; 295(6590):96. PubMed ID: 3113653
[No Abstract] [Full Text] [Related]
31. The treatment of patients with polycystic ovaries undergoing IVF.
Franks S
J Assist Reprod Genet; 1997 Jan; 14(1):12-4. PubMed ID: 9013303
[No Abstract] [Full Text] [Related]
32. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
33. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
[TBL] [Abstract][Full Text] [Related]
34. Induction of ovulation in amenorrheic patients with gonadotropin-releasing hormone and human menopausal gonadotropin.
Eckstein N; Vagman I; Eshel A; Naor Z; Ayalon D
Fertil Steril; 1985 Dec; 44(6):744-50. PubMed ID: 3935484
[TBL] [Abstract][Full Text] [Related]
35. The additional use of buserelin in HMG-HCG ovulation induction in PCO: a double blind controlled study.
Hompes PG; van Weissenbruch MM; Burger CW; Schoemaker J
Prog Clin Biol Res; 1986; 225():391-9. PubMed ID: 3097674
[No Abstract] [Full Text] [Related]
36. The effect of intravenous synthetic luteinizing hormone releasing hormone (LHRH) in infertile women with anovulation.
Pederden PH; Larsen JF; Micic S; Roos J; Sele V
Acta Obstet Gynecol Scand Suppl; 1974; 29():89-95. PubMed ID: 4601472
[No Abstract] [Full Text] [Related]
37. Induction of ovulation and pregnancy with pulsatile luteinizing hormone releasing factor: dosage and mode of delivery.
Reid RL; Leopold GR; Yen SS
Fertil Steril; 1981 Nov; 36(5):553-9. PubMed ID: 6796436
[TBL] [Abstract][Full Text] [Related]
38. Continuous subcutaneous infusion of human menopausal gonadotropin in anovulatory women with decreased FSH/LH ratio and androgen excess.
Kuroda G; Yano K; Suginami H
Endocrinol Jpn; 1988 Feb; 35(1):27-37. PubMed ID: 3135179
[TBL] [Abstract][Full Text] [Related]
39. Synergism of pulsatile LHRH therapy with oral clomiphene treatment.
Homburg R; Eshel A; Armar NA; Tucker M; Adams J; Jacobs HS
Gynecol Endocrinol; 1988 Mar; 2(1):59-66. PubMed ID: 3140591
[TBL] [Abstract][Full Text] [Related]
40. Failure to improve ovarian response by combined gonadotropin-releasing hormone agonist and gonadotropin therapy.
Bider D; Kokia E; Lipitz S; Blankstein J; Mashiach S; Serr DM; Ben-Rafael Z
Gynecol Obstet Invest; 1990; 29(3):192-6. PubMed ID: 2113505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
